Search research articles
Contact Us
Filters
Showing results (121-130 of 373) with videos related to
Page
of 38
Sort By:
International Journal of Cancer
|
September 25, 2008
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells
Weiyun Z Ai, Jing-Zhou Hou, Robert Zeiser, et al.
Cell Reports Methods
|
October 18, 2025
AIstain: Enhancing microglial phagocytosis analysis through deep learning
Alexander Zähringer, Janaki Manoja Vinnakota, Tobias Wertheimer, et al.
Clinical Transplantation
|
July 13, 2005
Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation
Björn Hackanson, Robert Zeiser, Thorsten A Bley, et al.
Bone Marrow Transplantation
|
November 20, 2024
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
Thomas Meyer, Kristina Maas-Bauer, Ralph Wäsch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2007
Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease
Robert Zeiser, Elizabeth A Zambricki, Dennis Leveson-Gower, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Ruxolitinib
Stefanie Ajayi, Heiko Becker, Heike Reinhardt, et al.
Transplantation
|
May 29, 2004
Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation
Claudia I Müller, Robert Zeiser, Carsten Grüllich, et al.
Blood
|
August 7, 2020
Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness
Mohamad Mohty, Ernst Holler, Madan Jagasia, et al.
Bone Marrow Transplantation
|
November 6, 2024
Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease
Zahra Mahmoudjafari, Valkal Bhatt, John Galvin, et al.
BMC Cancer
|
November 21, 2018
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, et al.
Page
of 38
Search research articles
Search
Showing results (121-130 of 373) with videos related to
Sort By:
Page
of 38
International Journal of Cancer
|
September 25, 2008
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells
Weiyun Z Ai, Jing-Zhou Hou, Robert Zeiser, et al.
Cell Reports Methods
|
October 18, 2025
AIstain: Enhancing microglial phagocytosis analysis through deep learning
Alexander Zähringer, Janaki Manoja Vinnakota, Tobias Wertheimer, et al.
Clinical Transplantation
|
July 13, 2005
Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation
Björn Hackanson, Robert Zeiser, Thorsten A Bley, et al.
Bone Marrow Transplantation
|
November 20, 2024
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
Thomas Meyer, Kristina Maas-Bauer, Ralph Wäsch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2007
Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease
Robert Zeiser, Elizabeth A Zambricki, Dennis Leveson-Gower, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Ruxolitinib
Stefanie Ajayi, Heiko Becker, Heike Reinhardt, et al.
Transplantation
|
May 29, 2004
Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation
Claudia I Müller, Robert Zeiser, Carsten Grüllich, et al.
Blood
|
August 7, 2020
Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness
Mohamad Mohty, Ernst Holler, Madan Jagasia, et al.
Bone Marrow Transplantation
|
November 6, 2024
Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease
Zahra Mahmoudjafari, Valkal Bhatt, John Galvin, et al.
BMC Cancer
|
November 21, 2018
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, et al.
Page
of 38